Position in CHRS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$423,538
-$124,246 QoQ
Shares Held
302,528
-6.7% QoQ
Ownership
0.196%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#28
of 145 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in CHRS Over Time
Shares Held
Position Value (USD)
Derivatives in CHRS
reported options exposure · as of Jun 30, 2022CallValue
$195,480
CallShares
27,000
PutValue
$195,480
PutShares
27,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. CHRS ranks #251 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in CHRS
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $423,538 | 302,528 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $547,784 | 324,133 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $158,616 | 111,703 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $124,316 | 75,803 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $60,340 | 82,547 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $85,795 | 106,315 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $211,597 | 153,332 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $688,146 | 661,680 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $475,914 | 275,095 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $5,801,067 | 2,427,225 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $7,055,616 | 2,118,804 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $5,511,198 | 1,473,583 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $722,375 | 169,175 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $3,880,837 | 567,374 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $3,029,002 | 382,450 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $2,605,077 | 271,080 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $195,480 | 27,000 | Call | Defined | 2022-08-12 | |
| 2022-06-30 | $1,539,497 | 212,638 | Shares | Defined | 2022-08-12 | |
| 2022-06-30 | $195,480 | 27,000 | Put | Defined | 2022-08-12 | |
| 2022-03-31 | $3,183,513 | 246,593 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $3,291,157 | 206,213 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $4,222,343 | 262,747 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $3,484,978 | 251,987 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $2,155,323 | 147,524 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $2,501,728 | 143,943 | Shares | Defined | 2021-02-10 | |
| 2020-12-31 | $709,104 | 40,800 | Call | Defined | 2021-02-10 | |
| 2020-09-30 | $1,388,574 | 75,713 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $1,472,733 | 82,460 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $1,459,667 | 89,992 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||